Snowball logo
logo
0DL

BIOSYNEX INH. EO-10

€0.81+€0.054  (7.14%)
Estimate
EPS
-4.03
Beta
0.828
About the company
Ticker
0DL
ISIN
FR0011005933
Country
France
Sector (GICS)
Healthcare
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products, as well as anti-mosquito bracelets and waterproof, moisturizing, and sensitive skin spray. The company was incorporated in 2005 and is based in Illkirch-Graffenstaden, France.

Frequently asked questions

What sector does BIOSYNEX INH. EO-10 (0DL) operate in?

BIOSYNEX INH. EO-10 belongs to the Healthcare sector and operates in the Medical Devices industry.

What is BIOSYNEX INH. EO-10 (0DL) current stock price?

As of the latest data, BIOSYNEX INH. EO-10 stock price is €0.81, with a previous close of €0.76. BIOSYNEX INH. EO-10 gained €0.05 in the last trading session, representing a 7.14% increase.

What is BIOSYNEX INH. EO-10 (0DL) current market capitalization?

BIOSYNEX INH. EO-10 market cap is approximately 14.93 million.

What is BIOSYNEX INH. EO-10 (0DL) Earnings Per Share (EPS)?

The trailing EPS is -€4.03.

Does BIOSYNEX INH. EO-10 (0DL) pay dividends?

No. BIOSYNEX INH. EO-10 does not pay a dividend.

What is BIOSYNEX INH. EO-10 (0DL) beta (volatility) score?

BIOSYNEX INH. EO-10 has a beta of 0.828, meaning its volatility is roughly in line with the market.